All cohorts had numerical improvements in 6MWD but did not reach statistical significance (20 participants had improvements while 12 (four in each cohort) had reductions in 6MWD).
← all excerpts
Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension.
1
—
—